U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict

Wall Street is trying to figure out whether the U.S. insurance industry will bear any costs from a record $4.69 billion judgment against Johnson & Johnson awarded to customers and their families who claimed that asbestos-contaminated talc caused ovarian cancer.

…read more

Source:: Reuters – Business News